Patients with end-stage kidney disease (ESKD) constitute...
Artículos Científicos en Ingles
Artículos Científicos RSS AJKD
Reducing Elevated Parathyroid Hormone to Protect Bone Strength in End-Stage Kidney Disease | Improvements in Kidney Outcomes Over the Years: Reason for Optimism but a Challenge for TrialistsChronic kidney disease (CKD) is common, costly, and a... | Metabolites Associated With Uremic Symptoms in Patients With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) StudyThe toxins that contribute to uremic symptoms in... |
Potentially Inappropriately Medication Prescriptions Among Medicare Patients Receiving HemodialysisTreatment of patients with end stage kidney disease (... | Monoclonal Immunoglobulin Crystalline Membranous NephropathyMonoclonal immunoglobulin (MIg) crystalline... | Quantity Versus Quality of Anti–Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate ContinuesMembranous nephropathy (MN) is a common cause of adult... |


